FDA Approves Inluriyo-Verzenio Combination for ESR1-Mutated Breast Cancer
The all-oral treatment is approved for certain adults with advanced or metastatic ... more
The all-oral treatment is approved for certain adults with advanced or metastatic ... more
The new once-daily pill nearly doubled median survival in a major trial. ... more
Merck and Moderna say their personalized mRNA therapy helped delay melanoma recurrence ... more
Precision medicines are helping some breast cancer patients live longer with fewer ... more
Daraxonrasib is not fully approved yet, but the FDA has opened access ... more
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Connect with us